Related Experiment Videos

Staged thrombolysis and percutaneous transluminal coronary angioplasty for unstable and postinfarction angina

D V Hurley1, D R Bresnahan, D R Holmes

  • 1Mayo Clinic, Rochester, MN 55905.

Insights

Staged thrombolysis followed by deferred angioplasty is a viable treatment for acute coronary syndromes. This approach helps reduce the risk of acute occlusion during coronary angioplasty in patients with unstable angina.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Coronary angioplasty is effective for unstable angina and postinfarction angina but carries a significant risk of thromboembolic coronary occlusion (24-29%).
  • The optimal timing for interventions like intravenous thrombolysis and coronary angioplasty in patients with coronary thrombosis remains under investigation.

Observation:

  • Three patients with intracoronary thrombus and acute coronary syndromes (unstable angina or postinfarction angina) were treated with a staged approach.
  • This approach involved initial intravenous thrombolysis and oral antiplatelet therapy, followed by deferred coronary angioplasty.

Findings:

  • The staged thrombolysis and deferred angioplasty strategy was successful in all three observed patients.
  • Adjunctive thrombolysis and antiplatelet therapy improved the success rate of angioplasty and decreased the risk of acute occlusion.

Implications:

  • Staged thrombolysis and deferred angioplasty is a feasible and effective strategy for selected patients presenting with acute coronary syndromes and intracoronary thrombus.
  • This approach offers a potential alternative to immediate angioplasty, mitigating risks associated with thromboembolic events.

Related Concept Videos